{
  "_metadata": {
    "version": "1.0",
    "type": "insights_index",
    "last_updated": "2026-02-11"
  },
  "articles": [
    {
      "slug": "fda-moderna-mrna-flu-vaccine",
      "title": "FDA Refuses to File Moderna\u2019s mRNA Influenza Vaccine (mRNA-1010)",
      "summary": "CBER Director Vinay Prasad overruled career FDA reviewers to reject Moderna\u2019s mRNA flu vaccine application. Sector-wide implications for mRNA platform valuation and CBER regulatory risk across vaccines, gene therapies, and cell therapies.",
      "category": "regulatory",
      "label": "Flash Note",
      "date": "2026-02-11",
      "date_display": "February 11, 2026",
      "author": "Satya Bio Research",
      "reading_time": "12 min read",
      "key_data": [
        {"key": "Candidate", "value": "mRNA-1010"},
        {"key": "Phase 3 Efficacy", "value": "+26.6% vs. Standard-Dose"},
        {"key": "Safety Signals", "value": "None Identified"},
        {"key": "Ex-US Status", "value": "Accepted (EU, CA, AU)"}
      ]
    }
  ],
  "categories": {
    "regulatory": {
      "name": "Regulatory",
      "color": "#1b2d45",
      "bg": "rgba(27, 45, 69, 0.08)"
    },
    "landscape": {
      "name": "Landscape",
      "color": "#1b2d45",
      "bg": "rgba(27, 45, 69, 0.06)"
    },
    "deals": {
      "name": "Deals",
      "color": "#d4805a",
      "bg": "rgba(212, 128, 90, 0.08)"
    },
    "catalyst": {
      "name": "Catalyst",
      "color": "#2c4263",
      "bg": "rgba(44, 66, 99, 0.06)"
    }
  }
}
